PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy

Journal of the Chinese Medical Association

Volumn 74, Issue 12, 2011, Pages 552-555

  Chen, Chuan Shu ^a   Wang, Shian Shiang ^a   Li, Jian Ri ^a   Cheng, Chen Li ^a   Yang, Chi Rei ^a   Chen, Wen Ming ^a   Ou, Yen Chuan ^a   Ho, Hao Chung ^a   Chiu, Kun Yuan ^a   Yang, Cheng Kuang ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Biopsy; Density; Men's health; Prostate cancer; Prostate specific antigen; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VELOCITY;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84455169457     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.10.004     Document Type: Article

References (18)

1. Matsuda T., Saika K. Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols. IV-IX. Jpn J Clin Oncol 2009, 39:468-469.
2. Matsuda T., Saika K. Comparison of time trends in prostate cancer incidence (1973-1997) in East Asia, Europe and USA, from cancer incidence in five continents, Vols. IV-VIII. Jpn J Clin Oncol 2007, 37:556-557.
3. Stamey T.A., Yang N., Hay A.R., McNeal J.E., Freiha F.S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987, 317:909-916.
4. Luboldt H.J., Bex A., Swoboda A., Husing J., Rubben H. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff. Eur Urol 2001, 39:131-137.
5. Luderer A.A., Chen Y.T., Soriano T.F., Kramp W.J., Carlson G., Cuny C., et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995, 46:187-194.
6. Di Donna A., Bazzocchi M., Guerra U.P., Bendini M., De Biasi F., Caminiti F., et al. The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma: a comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy. Radiol Med 1993, 85:84-89.
7. Partin A.W., Catalona W.J., Southwick P.C., Subong E.N., Gasior G.H., Chan D.W. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 1996, 48(Suppl):55-61.
8. Connolly D., Black A., Murray L.J., Napolitano G., Gavin A., Keane P.F. Methods of calculating prostate-specific antigen velocity. Eur Urol 2007, 52:1044-1050.
9. Levine M.A., Ittman M., Melamed J., Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998, 159:471-476.
10. Mian B.M., Naya Y., Okihara K., Vakar-Lopez F., Troncoso P., Babaian R.J. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002, 60:836-840.
11. Stewart C.S., Leibovich B.C., Weaver A.L., Lieber M.M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001, 166:86-92.
12. Yang C.R., Su C.K., Chiu K.Y., Ho H.C., Ou Y.C., Cheng C.L., et al. Free / total prostate specific antigen ratio for prostate cancer detection: a prospective blind study. Anticancer Res 2005, 25:2439-2443.
13. Djavan B., Zlotta A., Remzi M., Ghawidel K., Basharkhah A., Schulman C.C., et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 2000, 163:1144-1149.
14. Djavan B., Zlotta A.R., Byttebier G., Shariat S., Omar M., Schulman C.C., et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998, 160:411-419.
15. Shen J.T., Guo W.H., Xin X.Y., Jia Z.J., Xu P., Shi M. ROC curve analysis of fPSA/tPSA and PASD for prostate cancer with tPSA in diagnostic gray zone. J Mod Lab Med 2007, 5:64-66.
16. Vickers A.J., Savage C., O'Brien M.F., Lilja H. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. J Clin Oncol 2009, 27:398-403.
17. Perkins N.J., Schisterman E.F. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006, 163:670-675.
18. Akobeng A.K. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647.